Dr. Michael Edward Merhige, MD

Dr. Merhige practices at Niagara Falls Memorial Medical Center in Niagara Falls, New York, part of Niagara Falls Memorial Medical Center.

Dr. Merhige's NPI, 1902887128, was assigned on November 7, 2005. Dr. Merhige graduated from University of Kentucky College of Medicine in 1980. Dr. Merhige holds New York license 177176.

Dr. Merhige's primary practice is Niagara Falls Memorial Medical Center, at 621 Tenth Street, Niagara Falls, NY 14302 in Niagara County. The practice phone is (716) 278-4000.

Dr. Merhige's primary practice is Niagara Falls Memorial Medical Center in Niagara Falls, New York, part of Niagara Falls Memorial Medical Center. Dr. Merhige is also affiliated with Sisters of Charity Hospital. The medical group on file is Merhige Cardiology. Dmand AI also links Dr. Merhige to 1 more hospital, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Merhige practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Merhige's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Merhige is licensed in New York.

CMS data shows 869 Medicare services from Dr. Merhige across 15 procedure codes in 2024, for 126 Medicare patients. Medicare paid $102,315 for them. Every service was in an office.

CMS counts 126 Medicare patients who saw Dr. Merhige in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Merhige's median patient age at 75, with 42% women.

In 2024, Dr. Merhige wrote 5,274 Medicare Part D claims for 358 patients. 90% of them were for generic drugs. CMS names the drug for 5,027 of them, across 46 drugs with 11 or more claims each, at $570,378 in total drug cost. In 2023, CMS named 5,419 claims across 54 drugs.

Dr. Merhige accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Merhige, published from 2012 to 2020. 2014 was the busiest year, with 4. The most frequent topics are Myocardial Perfusion Imaging, Positron-Emission Tomography and Coronary Artery Disease. Dr. Merhige has published most often in JACC Cardiovasc Imaging. Dr. Merhige's most frequent co-authors are Brent Allan Williams, MD, Daniel S. Berman, MD and Naveen Bellam, MD.

CMS Open Payments shows 247 general payments to Dr. Merhige from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $480.

Dr. Merhige graduated from University of Kentucky College of Medicine in 1980.